You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDX-1140

Showing 26 - 50 of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in United States (Bevacizumab, Rindopepimut (CDX-110) with

Completed
  • Glioblastoma
  • +6 more
  • Birmingham, Alabama
  • +44 more
Feb 12, 2020

Healthy Trial in Perth (CDX-6114, Placebo)

Completed
  • Healthy
  • Perth, Western Australia, Australia
    Linear Clinical Services
Aug 2, 2021

Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial

Recruiting
  • Metastatic Distal Bile Duct Adenocarcinoma
  • +9 more
  • Atezolizumab
  • +6 more
  • Phoenix, Arizona
  • +28 more
Dec 31, 2022

Prostate Cancer Trial in New York (PGV-001, Poly-ICLC, CDX-301)

Recruiting
  • Prostate Cancer
  • PGV-001
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai (ISMMS)
Aug 10, 2021

Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +2 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2021

NSCLC (NSCLC) Trial in Bronx (FLT3 Ligand Therapy (CDX-301), Stereotactic Body Radiotherapy (SBRT))

Active, not recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • FLT3 Ligand Therapy (CDX-301)
  • Stereotactic Body Radiotherapy (SBRT)
  • Bronx, New York
    Montefiore Medical Center
Nov 5, 2021

WATS3D for the Detection of Esophageal Dysplasia

Completed
  • Barrett Esophagus
  • +2 more
  • Diagnostic Test
  • Philadelphia, Pennsylvania
    Mike Smith
Oct 27, 2021

Phenylketonurias Trial (cohort 1 0.225g, Cohort 2 0.75g, Cohort 3 2.25 g)

Withdrawn
  • Phenylketonurias
  • cohort 1 0.225g
  • +2 more
  • (no location specified)
Sep 11, 2020

Pancreatic Adenocarcinoma Trial in Manchester (Portal vein sampling)

Recruiting
  • Pancreatic Adenocarcinoma
  • Portal vein sampling
  • Manchester, United Kingdom
  • +1 more
Feb 1, 2022

Healthy Subjects Trial in Overland Park (CDX-0159, Normal saline)

Completed
  • Healthy Subjects
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Jul 2, 2020

Acute Myeloid Leukemia Trial in Spain (OPB-111077)

Completed
  • Acute Myeloid Leukemia
  • Cáceres, Extremadura, Spain
  • +5 more
Feb 10, 2021

Phenylketonuria Trial in Nedlands, Neuss (CDX 6114, Matching Placebo)

Completed
  • Phenylketonuria
  • CDX 6114
  • Matching Placebo
  • Nedlands, Western Australia, Australia
  • +1 more
Sep 11, 2020

Renal Cell Carcinoma (RCC), Clear-cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in United States (CDX-014)

Terminated
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • Scottsdale, Arizona
  • +4 more
Jun 2, 2020

Melanoma Trial in New York, Philadelphia (Trametinib daily Until PD, CDX-3379 (ERBB3 antibody))

Terminated
Has Results
  • Melanoma
  • Trametinib daily Until PD
  • CDX-3379 (ERBB3 antibody)
  • New York, New York
  • +1 more
May 12, 2020

Laryngeal Disease, Laryngeal Tumor, Laryngopharyngeal Reflux Trial (Endo CDx Brush biopsy)

Withdrawn
  • Laryngeal Disease
  • +2 more
  • Endo CDx Brush biopsy
  • (no location specified)
Jul 16, 2020

Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 18, 2021

Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Buffalo

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 16, 2020

Bladder Cancer Trial in United States (CDX-1307 Vaccine Regimen, Chemotherapy)

Terminated
  • Bladder Cancer
  • Phoenix, Arizona
  • +16 more
Feb 10, 2020

End-stage Kidney Disease Trial in Pittsburgh (Talking About Living Kidney Donation, Kidney Transplant Fast Track)

Completed
  • End-stage Kidney Disease
  • Talking About Living Kidney Donation
  • Kidney Transplant Fast Track
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Jan 4, 2021

Metastatic gpNMB Over-expressing Triple Negative Breast Cancer Trial in Worldwide (CDX-011, Capecitabine)

Completed
Has Results
  • Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
  • Birmingham, Alabama
  • +139 more
Mar 6, 2019

Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic

Recruiting
  • Untreated Advanced NSCLC Patients
  • FISH Identified ALK Fusion Positive or Negative
  • ALK inhibitor
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Jul 31, 2020

Advanced Cancer Trial in Boston, Portland, Nashville (CDX-0158 (formerly known as KTN-0158))

Completed
  • Advanced Cancer
  • CDX-0158 (formerly known as KTN-0158)
  • Boston, Massachusetts
  • +3 more
Jun 11, 2019

Breast Cancer Trial in Seoul (FoundationOne CDx)

Unknown status
  • Breast Cancer
  • FoundationOne CDx
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 19, 2019

Healthy Trial in Perth (CDX-6114, Placebo)

Completed
  • Healthy
  • Perth, Western Australia, Australia
    Linear Clinical Services
Sep 18, 2018